Literature DB >> 11408763

Gene expression accompanied by differentiation of cord blood-derived CD34+ cells to eosinophils.

R Hashida1, K Ogawa, M Miyagawa, Y Sugita, K Matsumoto, A Akasawa, H Saito.   

Abstract

To clarify the relation between the expression of genes such as eosinophil-specific granular proteins and cytokine receptors and the pathogenesis of allergic disease, cord blood-derived CD34+ cells were cultured and differentiated into eosinophils. Gene expression in the cells during the differentiation was determined by real-time reverse transcription PCR (ABI PRISM 7700). CD34+ mononuclear cells cultured with stem cell factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-3, and IL-5 in Iscove's MEM, and proliferated until the 2nd week, when the cell number reached a plateau. Under these conditions, more than 90% of the cells differentiate into mature eosinophils in 3 weeks. The expression of major basic protein and eosinophil-derived neurotoxin in the treated cells increased until week 2 and decreased between week 2 and 3. However, the expression of membrane receptor genes, such as IL-5 receptor (alpha chain), IL-3 receptor (alpha chain), GM-CSF-alpha receptor, GM-CSF-beta receptor, CC chemokine receptor 3, interferon-gamma receptor, platelet-activating factor receptor and leukotriene D4 receptor, increased until the 3rd week of eosinophil maturation. Our study suggests that the in vitro eosinophil differentiation and maturation model is useful for clarifying the relation between eosinophil-specific gene expression during allergic diseases and the progression of the disease. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408763     DOI: 10.1159/000053843

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils.

Authors:  K Ogawa; R Hashida; M Miyagawa; S Kagaya; Y Sugita; K Matsumoto; T Katsunuma; A Akasawa; G Tsujimoto; H Saito
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

2.  Personalized Radioproteomics: Identification of a Protein Biomarker Signature for Preemptive Rescue by Tocopherol Succinate in CD34+ Irradiated Progenitor Cells Isolated from a Healthy Control Donor.

Authors:  Anjali Srivastava; Ximena Leighton; Ofer Eidelman; Joshua Starr; Catherine Jozwik; Meera Srivastava; Harvey B Pollard; Vijay K Singh
Journal:  J Proteomics Bioinform       Date:  2015-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.